+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
FEMALE
ID06830382

Study Using 68GaGa-ABY-025 PET Imaging to Guide Treatment with HER2-Targeted Therapy in Women with Metastatic HER2-Expressing Breast Cancer

Led by Renske Altena · Updated on 2025-11-20

70

Participants Needed

1

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating metastatic breast cancer in women who have received at least one prior systemic therapy. This trial focuses on using a special imaging technique called positron emission tomography PET with a tracer called 68GaGa-ABY-025 to better understand HER2 expression in tumors. The goal is to see if this precise imaging can help doctors plan treatments more effectively, particularly with the drug trastuzumab deruxtecan T-DXd, and improve patient outcomes while reducing side effects. Participants will undergo an initial HER2-PET scan and a tumor biopsy guided by the scan results. Those with HER2-expressing tumors will receive treatment with T-DXd. After 9 to 12 weeks of treatment, a second HER2-PET scan will evaluate how well the treatment is working. An optional third scan and biopsy may be done if the disease progresses. Patients without HER2 expression will be monitored for side effects after the imaging before ending participation. Throughout the study, patients will have biopsies of accessible metastatic lesions and tumor evaluations using CT scans. Researchers will assess treatment response, changes in HER2 expression, and quality of life at multiple points. Safety monitoring includes tracking adverse events for patients without HER2 expression. Overall, this study aims to last until disease progression or withdrawal, with follow-up assessments scheduled at key treatment milestones to understand the benefits of HER2-PET imaging combined with T-DXd therapy.

CONDITIONS

Brief Title

HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBC

Research Team

T

Thuy Tran, Associate Prof, PharmD, PhD

R

Renske Altena, Associate Professor, MD PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here